ID29864A - USE OF 17-CETOSTEROID DEGREE AND DEGREE, METABOLITES AND ITS PRECURSORS IN TREATMENT OF VIRUS HEPATITIS C AND OTHER TOGAVIRUS - Google Patents
USE OF 17-CETOSTEROID DEGREE AND DEGREE, METABOLITES AND ITS PRECURSORS IN TREATMENT OF VIRUS HEPATITIS C AND OTHER TOGAVIRUSInfo
- Publication number
- ID29864A ID29864A IDW00200101129A ID20011129A ID29864A ID 29864 A ID29864 A ID 29864A ID W00200101129 A IDW00200101129 A ID W00200101129A ID 20011129 A ID20011129 A ID 20011129A ID 29864 A ID29864 A ID 29864A
- Authority
- ID
- Indonesia
- Prior art keywords
- degree
- cetosteroid
- togavirus
- metabolites
- precursors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10992498P | 1998-11-24 | 1998-11-24 | |
| US12408799P | 1999-03-11 | 1999-03-11 | |
| US12605699P | 1999-03-23 | 1999-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID29864A true ID29864A (en) | 2001-10-18 |
Family
ID=27380740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW00200101129A ID29864A (en) | 1998-11-24 | 1999-11-24 | USE OF 17-CETOSTEROID DEGREE AND DEGREE, METABOLITES AND ITS PRECURSORS IN TREATMENT OF VIRUS HEPATITIS C AND OTHER TOGAVIRUS |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1133287A2 (en) |
| JP (1) | JP2002531397A (en) |
| KR (1) | KR20010101074A (en) |
| CN (1) | CN1328463A (en) |
| AP (1) | AP2001002181A0 (en) |
| AU (1) | AU775614B2 (en) |
| BR (1) | BR9915644A (en) |
| CA (1) | CA2352205A1 (en) |
| HK (1) | HK1042426A1 (en) |
| ID (1) | ID29864A (en) |
| IL (2) | IL142942A0 (en) |
| NZ (1) | NZ511721A (en) |
| OA (1) | OA11716A (en) |
| WO (1) | WO2000032177A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667299B1 (en) | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| CA2375647A1 (en) | 1999-07-08 | 2001-01-18 | Patrick T. Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| DK1955700T3 (en) | 1999-09-30 | 2011-05-23 | Harbor Biosciences Inc | Therapeutic treatment of androgen receptor-related disorders |
| US8476254B2 (en) | 2002-07-02 | 2013-07-02 | Corcept Therapeutics, Inc. | Methods for treating psychosis associated with interferson-α therapy |
| EP2298315A1 (en) * | 2002-08-28 | 2011-03-23 | Harbor BioSciences, Inc. | Therapeutic treatment methods |
| KR101435242B1 (en) * | 2007-11-15 | 2014-08-29 | 마다우스 게엠베하 | Silibinin component for the treatment of hepatitis |
| CN102993148B (en) * | 2011-09-13 | 2015-12-09 | 复旦大学 | Quercetin derivative or its analogue and application thereof |
| WO2013178782A1 (en) * | 2012-05-30 | 2013-12-05 | Universidad De Zaragoza | Allosteric inhibitors of ns3 protease from hepatitis c virus |
| CN108003212A (en) * | 2017-12-24 | 2018-05-08 | 扬州工业职业技术学院 | A kind of dehydroepiandros-sterone -6- glucoside derivatives and its application as anti hepatitis C virus drug |
| CN110452280B (en) * | 2019-07-25 | 2020-11-17 | 中国人民解放军第二军医大学 | Tetracyclic triterpenic acid derivative and preparation method and application thereof |
| JP2023543352A (en) * | 2020-09-22 | 2023-10-13 | マイクロナイゼーション テクノロジーズ アンド セラピューティクス グループ エルエルシー | Nebulizers and atomized antivirals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL194728C (en) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Pharmaceutical preparation suitable for the prophylaxis or therapy of a retroviral infection or a complication or consequence thereof. |
| US5837269A (en) * | 1989-09-25 | 1998-11-17 | University Of Utah Research Foundation | Vaccine compositions and method for enhancing an immune response |
| EP0901375A1 (en) * | 1996-04-17 | 1999-03-17 | Patrick Thomas Prendergast | Dhea combination therapy |
| AU5221998A (en) * | 1997-04-17 | 1998-11-13 | Patrick T. Prendergast | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors |
-
1999
- 1999-11-24 CA CA002352205A patent/CA2352205A1/en not_active Abandoned
- 1999-11-24 ID IDW00200101129A patent/ID29864A/en unknown
- 1999-11-24 NZ NZ511721A patent/NZ511721A/en unknown
- 1999-11-24 KR KR1020017006525A patent/KR20010101074A/en not_active Application Discontinuation
- 1999-11-24 AP APAP/P/2001/002181A patent/AP2001002181A0/en unknown
- 1999-11-24 JP JP2000584873A patent/JP2002531397A/en active Pending
- 1999-11-24 BR BR9915644-0A patent/BR9915644A/en not_active Application Discontinuation
- 1999-11-24 CN CN99813658A patent/CN1328463A/en active Pending
- 1999-11-24 AU AU31052/00A patent/AU775614B2/en not_active Ceased
- 1999-11-24 WO PCT/US1999/028082 patent/WO2000032177A2/en not_active Application Discontinuation
- 1999-11-24 EP EP99965050A patent/EP1133287A2/en not_active Withdrawn
- 1999-11-24 OA OA1200100128A patent/OA11716A/en unknown
- 1999-11-24 IL IL14294299A patent/IL142942A0/en active IP Right Grant
-
2001
- 2001-05-03 IL IL142942A patent/IL142942A/en not_active IP Right Cessation
-
2002
- 2002-03-25 HK HK02102267.0A patent/HK1042426A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1133287A2 (en) | 2001-09-19 |
| BR9915644A (en) | 2001-08-07 |
| OA11716A (en) | 2005-01-25 |
| NZ511721A (en) | 2004-07-30 |
| AP2001002181A0 (en) | 2001-05-24 |
| IL142942A0 (en) | 2002-04-21 |
| AU3105200A (en) | 2000-06-19 |
| KR20010101074A (en) | 2001-11-14 |
| AU775614B2 (en) | 2004-08-05 |
| JP2002531397A (en) | 2002-09-24 |
| CA2352205A1 (en) | 2000-06-08 |
| WO2000032177A3 (en) | 2001-03-22 |
| HK1042426A1 (en) | 2002-08-16 |
| IL142942A (en) | 2006-08-20 |
| WO2000032177A2 (en) | 2000-06-08 |
| CN1328463A (en) | 2001-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID27457A (en) | COMPOSITION FOR HIV TREATMENT AND OTHER VIRUS INFECTIONS | |
| ID21863A (en) | COMPOUNDS OF KINOLIN AND KINAZOLIN USED IN THERAPY, SPECIFICALLY IN TREATMENT OF TYPICAL PROSTATIC HEPERPLASIA | |
| IS5510A (en) | Compounds that act against "picorna" viruses and their methods of use and construction | |
| ID26244A (en) | BENZOTIOFENSES, BENZOFURANS, AND INDOLS USED IN INSULIN AND HYPERGILLIC RESISTANT TREATMENT | |
| ID21019A (en) | PIRAZOL DISTRIBUTION, IT IS CREATED AND USED IN PHARMACEUTICAL PROPERTIES | |
| GB9609932D0 (en) | Use of IL-12 and IFN alpha for the treatment of infectious diseases | |
| EE200000145A (en) | New use of budesonide and formoterol | |
| DE69836008D1 (en) | COMPOSITION AND TREATMENT AGENT | |
| KR970704430A (en) | USE OF DROLOXIFENE FOR THE TREATMENT OF PROSTATIC DISEASES ENDOMETRIOSIS AND OBESITY | |
| ID27922A (en) | PHARMACICAL COMPOSITION AND USE OF ANDROST-5-ENA-3β, 17β-DIOL | |
| DE69739758D1 (en) | VACCINE FOR THE TREATMENT OF LYMPHOMA AND LEUKEMIA | |
| HUP9903829A3 (en) | Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof | |
| DE69831755D1 (en) | OPTOACUSTIC CONSTANCES AND METHOD OF USE | |
| ID29298A (en) | METHOD AND COMPOSITION TO TREAT APNEA DURING SLEEP | |
| FI965250A0 (en) | Concentration of the gas component in the gas component and the gas component in the concentration | |
| ID23514A (en) | MONOLEFINIC C5 MONONITRIL, MANUFACTURE AND USE OF IT | |
| ID29864A (en) | USE OF 17-CETOSTEROID DEGREE AND DEGREE, METABOLITES AND ITS PRECURSORS IN TREATMENT OF VIRUS HEPATITIS C AND OTHER TOGAVIRUS | |
| ID19548A (en) | RECOMBINED MVA VIRUSES EXPRESSING FEATURES ANTIGENS AND FEVER USING THEMS IN VACCINES | |
| DE69715482T2 (en) | Preparation of 1,1,1,3,3-pentachlorobutane and 1,1,1,3,3-pentafluorobutane | |
| ID24196A (en) | COMPOSITION AND USE | |
| DE60035497D1 (en) | PROCEDURE FOR PRESERVING VIRUSES AND MYCOPLASMA | |
| ID26572A (en) | COMPOSITION OF SKIN AND HAIR DAMPERS | |
| ID27510A (en) | SUBSTITUTIONAL MALIMIDE COMPOUNDS AND PHARMACY USE | |
| DE69808714D1 (en) | Hydrosilylation catalyst and hydrosilylation process | |
| ID24910A (en) | HEMISULFATE NUCLEOSIDE CARBOXICATE AND USE IN VIRAL INFECTION TREATMENT |